Clinical Trial Update: Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety, tolerability, systemic exposure, and efficacy of GPB Cream in adolescents with primary axillary hyperhidrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axillary Hyperhidrosis

Drugs mentioned

• GPB Cream

Snippet

Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel | Conditions: Primary Axillary Hyperhidrosis | Phase 2 | Status: COMPLETED